Molbio Diagnostics Ltd

NSE: MOLBIO · BSE: 544866 · Healthcare · 8 announcements

Share price: ₹1,246.00
Market cap: ₹14,359 Cr
Revenue (annual): ₹1,446 Cr
Net profit (annual): ₹166.6 Cr
Promoter holding: 41.29%
FII holding: 1.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Earnings Call 2 Results Update 1 Financial Results 1 Capital Structure Change 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

7 Sep 2026 09:40 IST NSE

Results Update

Molbio Diagnostics Results Update

Molbio Diagnostics reported Q1 FY27 total income of ₹411.48 Cr and PAT of ₹52.74 Cr, a swing from prior-year losses. Growth was driven by Truenat test-kit volume and deferred Gulf export orders.

Read the filing ↗